1-Aminocyclobutanecarboxylic acid

CAS No. 22264-50-2

1-Aminocyclobutanecarboxylic acid( ACBC )

Catalog No. M27600 CAS No. 22264-50-2

1-Aminocyclobutanecarboxylic acid is a NMDA receptor partial agonist. 1-Aminocyclobutanecarboxylic acid act at the glycine site, NR1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 37 In Stock
25MG 74 In Stock
50MG 110 In Stock
100MG 159 In Stock
200MG 240 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-Aminocyclobutanecarboxylic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Aminocyclobutanecarboxylic acid is a NMDA receptor partial agonist. 1-Aminocyclobutanecarboxylic acid act at the glycine site, NR1.
  • Description
    1-Aminocyclobutanecarboxylic acid is a NMDA receptor partial agonist. 1-Aminocyclobutanecarboxylic acid act at the glycine site, NR1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ACBC
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    NMDAR
  • Recptor
    isoprenylcysteine carboxylmethyltransferase (ICMT)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    22264-50-2
  • Formula Weight
    115.132
  • Molecular Formula
    C5H9NO2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 27.78 mg/mL (241.29 mM)
  • SMILES
    NC1(CCC1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wan W, et al. Isoprenylcysteine carboxyl methyltransferase is critical for glioblastoma growth and survival by activating Ras/Raf/Mek/Erk. Cancer Chemother Pharmacol. 2022 Mar;89(3):401-411.
molnova catalog
related products
  • NMDA-IN-1

    NMDA-IN-1 is a potent and NR2B-selective antagonist of NMDA(NMDA Ki of 0.85 nM; NR2B Ca2+ influx IC50 is 9.7 nM).

  • Glabridin

    Glabridin may serve as an anti-inflammatory agent in diabetes-related vascular dysfunction, through regulating the synthesis and activity of iNOS under high-glucose levels.

  • 5,7-Dichlorokynureni...

    5,7-Dichlorokynurenic acid is an NMDA receptor antagonist.